About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

NIH Funds Drug Development Research For Neurodegenerative Disease

by Medindia Content Team on October 17, 2007 at 12:53 PM
Font : A-A+

NIH Funds Drug Development Research For Neurodegenerative Disease

Abnormal iron metabolism is linked to many neurodegenerative disorders, spurring scientists to search for ways to keep iron levels in balance and to develop drugs to correct an imbalance.

Daniel Kosman, Ph.D., professor of biochemistry in the School of Medicine and Biomedical Sciences, has received a two-year, $418,363 grant from the National Institutes of Health to develop a drug aimed at an iron-based neurodegenerative disease called aceruloplasminemia. This research complements the $1.16 million 4-year NIH grant Kosman received in June to study how iron is metabolized in cells.

Advertisement

Aceruloplasminemia occurs when the balance between the compartmentalization and storage of iron and the mobilization and transport of iron is disrupted. The condition is caused by a deficiency in the activity of the enzyme ceruloplasmin, which is essential for normal iron metabolism.

Kosman will be searching for a drug that can supplement the ceruloplasmin activity these patients lack. "Ceruloplasmin is required for the efficient trafficking of iron from the intestine to other organs in the body, such as the liver and pancreas," Kosman said. "Ceruloplasmin activity in the brain is even more important because a deficiency of this enzyme leads to neurodegeneration. It is likely that the failure to adequately manage the toxicity of iron in the brain is a component of all neurodegenerative disorders."
Advertisement

Kosman's research group has developed a method to produce human ceruloplasmin and to modify this protein and its yeast counterpart, Fet3p, into a form that will be stable in the bloodstream, a first requirement for any pharmacologic agent. These proteins will be furthered modified to target them to the brain.

Lynn Zeigler, senior research technician, and doctoral students Satadipta Chakraborty and Julie Spix collaborated on developing a method to produce human ceruloplasmin for these studies.

Kosman's group will test the therapeutic protein in a mouse strain genetically altered to exhibit the problems in iron metabolism observed clinically in humans. This work will be carried out in collaboration with Zena Leah Harris, M.D., a specialist in pediatric clinical care at Johns Hopkins University School of Medicine, and Jonathan D. Gitlin, M.D., professor of pediatrics and genetics at the Washington University School of Medicine.

Source: ANI
LIN/V
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Spinocerebellar Ataxia 

Recommended Reading
Clinical Trials - Drug development and Approval
The Drug development process is a complex one, where the experimental drug or treatments goes ......
800 Essential Proteins Connected With Cerebral Cortex Identified
A group of scientists have catalogued a comprehensive list of all the proteins found in the ......
Nervous Systems of Insects may Offer Clues on Neurodegenerative Diseases
By studying the addition of sugars to proteins — a process called glycosylation — in the nervous ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Spinocerebellar Ataxia
Spinocerebellar ataxia (SCA) is a progressive, neurodegenerative, genetic disease, which has no cur...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)